BIORESTORATIVE THERAPIES INC. - COMMON STOCK

2.3420

11-February-25 09:39:42

15 minutes delayed

Stocks

-0.0980

-4.02%

Today's range

2.3420 - 2.4000

ISIN

N/A

Source

NASDAQ

BioRestorative Therapies Announces Selection of 10 Clinical Sites for its Phase 2 Clinical Trial to Treat Chronic Lumbar Disc Disease

18 Apr 2022 08:00:00 By Nasdaq GlobeNewswire
BioRestorative Therapies Announces cGMP Cell Manufacturing Facility Certification

04 Apr 2022 08:00:02 By Nasdaq GlobeNewswire
BioRestorative Therapies Announces Research Collaboration with Professor Tore Bengtsson to Evaluate Heat Production of its ThermoStem® Program

10 Mar 2022 08:00:01 By Nasdaq GlobeNewswire
BioRestorative Therapies Announces Notice of Allowance on Key Patent for its BRTX-100® Disc Program

16 Feb 2022 08:30:00 By Nasdaq GlobeNewswire
BioRestorative Therapies Announces it has Initiated its Phase 2 Clinical Trial to Treat Chronic Lumbar Disc Disease – Site Selection Underway

07 Feb 2022 09:00:00 By Nasdaq GlobeNewswire
BioRestorative Therapies to Ring Nasdaq Stock Market Closing Bell

07 Feb 2022 07:45:00 By Nasdaq GlobeNewswire
BioRestorative Therapies Announces Notice of Allowance for New Patent Application in Japan and Expansion of ThermoStem® IP Portfolio

02 Feb 2022 08:00:01 By Nasdaq GlobeNewswire

<<
<
1
2
3
4
>

I Agree NetDania's website uses cookies. By continuing browsing our website, you agree to our Cookie Policy, Privacy Policy and Terms and Conditons.